Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-16

Clinical Trial Update: Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP) [Phase 3]

View source ↗

Summary

Phase 3 trial in psoriasis patients evaluating methotrexate with an optimized METOP schedule has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Prof. Kristian Reich | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED